Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs

Method of using 2-alkoxy-N-(1-azabicyclo[2.2.2]oct-3-yl)benzamide-N-oxides to control emesis caused by anticancer drugs

US Patent 4722834 · Granted Feb 2, 1988

Estimated economic value: $12,617,000 ⓘ

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Treatment of cardiovascular disease using ActRII ligand traps2023
Activin-ActRII antagonists and uses for treating bone and other disorders2019
Transmucosal administration of phosphodiesterase inhibitors for the treatment of2003
Administration of phosphodiesterase inhibitors for the treatment of premature ej2002
Administration of 5-HT receptor agonists and antagonists, to treat premature eja2001
Local administration of type III phosphodiesterase inhibitors for the treatment 2000
Local administration of Type IV phosphodiesterase inhibitors for the treatment o2000
Local administration of phosphodiesterase inhibitors for the treatment of erecti2000
Administration of 5-HT.sub.3 receptor antagonists to treat premature ejaculation2000
Local administration of pharmacologically active agents to treat premature ejacu1999
Tricyclic compounds acting at serotonin receptor subtypes1993
Tricyclic 5-HT.sub.3 receptor antagonists1993